⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
Baroda BNP ParibasBaroda BNP Paribas Health and Wellness Fund - Growth - Direct Plan
₹10.81 as on 30 Oct 2026
Key Metrics Comparison
| Metric | Baroda BNP Paribas Health and Wellness Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Baroda BNP Paribas | HDFC MF |
| Category | Equity - Sectoral Fund - Pharma & Health Care | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹10.81 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | BSE Health Care - TRI | BSE Health Care - TRI |
| Fund Manager | Sanjay Chawla | Nikhil Mathur |
| Inception | 27 Jun 2025 | 04 Oct 2023 |
| Returns | ||
| 1Y | 8.69% | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 5.08% | 29.15% |
| Risk | ||
| 11.43 | 14.07 | |
| 0.40 | 0.59 | |
| 0.01 | 1.59 | |
| 5.30 | 21.67 | |
| 0.03 | 3.48 | |
| -6.10% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.51% | 1.03% |
| Exit Load | NIL upto 10% of units and 1% for remaining units on or before 1Y, Nil after 1Y | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹500 | ₹100 |
| Min Lumpsum | ₹1,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Baroda BNP Pa…63%
HDFC MF63%
36.5%Only 36.5% of holdings by weight are common between Baroda BNP Paribas and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingBaroda BNP ParibasHDFC MF
Sun Pharmaceutical Industries Ltd.8.58%8.28%
Divi's Laboratories Ltd.7.82%9.39%
Apollo Hospitals Enterprise Ltd.5.28%3.69%
Torrent Pharmaceuticals Ltd.7.88%3.65%
Lupin Ltd.5.79%3.55%
Ipca Laboratories Ltd.6.13%2.98%
Acutaas Chemicals Ltd.2.36%3.18%
Aster DM Quality Care Ltd.2.15%3.56%
Glenmark Pharmaceuticals Ltd.3.11%2.09%
Category context: Equity vs Equity. Open the full Screener →